Inhibition of DNA Methylation by 1-Hr Infusion of 5-aza-2'-Deoxycitidine (Decitabine) x 10 Days (M-F) With Escalating Doses of Sub-Q Pegylated (PEG) Interferon-alpha 2B (PEG-Intron): A Phase I Study With Molecular Correlates
Phase of Trial: Phase I
Latest Information Update: 13 Dec 2013
At a glance
- Drugs Decitabine (Primary) ; Peginterferon alfa-2b (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 03 Jun 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 12 Oct 2010 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.
- 12 Oct 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.